Background: Dedifferentiated chondrosarcoma (DDC) accounts for a small proportion of
chondrosarcomas. They demonstrate aggressive behaviour with a high rate of local …

Simple Summary Dedifferentiated chondrosarcoma (DDCS) is a rare cancer that is
aggressive and leads to high patient mortality. There are limited data on the efficacy of …

Background. Dedifferentiated chondrosarcomas (DDCSs) are highly malignant tumors with
a dismal prognosis and present a significant challenge in clinical management. Methods. In …

Introduction The role of chemotherapy for patients with dedifferentiated chondrosarcoma
(DDCS) is still under discussion. Here, we present the outcome in patients with DDCS …

Dedifferentiated chondrosarcoma (DDCS) is a high-grade subtype of chondrosarcoma with
the bimorphic histological appearance of a conventional chondrosarcoma component with …

Simple Summary Dedifferentiated chondrosarcoma is a rare type of cancer that is very
aggressive and has a poor prognosis with poor survival rates. This disease can affect …

Background We report on 13 patients with dedifferentiated chondrosarcomas. The mean
age of the patients at diagnosis was 59.8 years. Nine patients were classified as stage IIB …

Background Dedifferentiated chondrosarcoma (DCS) is a rare and aggressive malignancy
with a poor prognosis. The purpose of this investigation was to describe our treatment and …

Background Dedifferentiated chondrosarcoma is a chondrosarcoma subtype associated
with high rates of recurrence and a poor prognosis. Others have proposed treatment of …

BACKGROUND: Dedifferentiated chondrosarcoma has a very poor prognosis. Because of
its rarity, there are few large studies of outcome which might identify potential prognostic …